Staar Surgical Co (STAA)
47.81
+1.22
(+2.62%)
USD |
NASDAQ |
Apr 23, 10:52
Staar Surgical Enterprise Value: 2.056B for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 2.056B |
| April 19, 2024 | 2.046B |
| April 18, 2024 | 2.065B |
| April 17, 2024 | 2.044B |
| April 16, 2024 | 2.057B |
| April 15, 2024 | 2.038B |
| April 12, 2024 | 2.212B |
| April 11, 2024 | 2.301B |
| April 10, 2024 | 2.275B |
| April 09, 2024 | 2.333B |
| April 08, 2024 | 2.198B |
| April 05, 2024 | 2.158B |
| April 04, 2024 | 2.003B |
| April 03, 2024 | 1.688B |
| April 02, 2024 | 1.712B |
| April 01, 2024 | 1.687B |
| March 28, 2024 | 1.650B |
| March 27, 2024 | 1.622B |
| March 26, 2024 | 1.538B |
| March 25, 2024 | 1.596B |
| March 22, 2024 | 1.584B |
| March 21, 2024 | 1.684B |
| March 20, 2024 | 1.715B |
| March 19, 2024 | 1.664B |
| March 18, 2024 | 1.656B |
| Date | Value |
|---|---|
| March 15, 2024 | 1.622B |
| March 14, 2024 | 1.638B |
| March 13, 2024 | 1.644B |
| March 12, 2024 | 1.619B |
| March 11, 2024 | 1.674B |
| March 08, 2024 | 1.532B |
| March 07, 2024 | 1.495B |
| March 06, 2024 | 1.514B |
| March 05, 2024 | 1.406B |
| March 04, 2024 | 1.465B |
| March 01, 2024 | 1.407B |
| February 29, 2024 | 1.306B |
| February 28, 2024 | 1.321B |
| February 27, 2024 | 1.376B |
| February 26, 2024 | 1.331B |
| February 23, 2024 | 1.278B |
| February 22, 2024 | 1.270B |
| February 21, 2024 | 1.264B |
| February 20, 2024 | 1.282B |
| February 16, 2024 | 1.285B |
| February 15, 2024 | 1.306B |
| February 14, 2024 | 1.238B |
| February 13, 2024 | 1.219B |
| February 12, 2024 | 1.309B |
| February 09, 2024 | 1.252B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
927.59M
Minimum
Jun 03 2019
7.539B
Maximum
Sep 07 2021
2.909B
Average
2.612B
Median
Dec 14 2022
Enterprise Value Benchmarks
| Anika Therapeutics Inc | 312.49M |
| The Cooper Companies Inc | 20.53B |
| OrthoPediatrics Corp | 646.67M |
| NexGel Inc | 12.18M |
| Innovative Eyewear Inc | -1.207M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 7.756M |
| Revenue (Quarterly) | 76.27M |
| Total Expenses (Quarterly) | 65.87M |
| EPS Diluted (Quarterly) | 0.16 |
| Gross Profit Margin (Quarterly) | 79.62% |
| Profit Margin (Quarterly) | 10.17% |
| Earnings Yield | 0.90% |
| Operating Earnings Yield | 1.19% |
| Normalized Earnings Yield | 0.9525 |